(XNPT:Consolidated Issue Listed on NASDAQ Global Select )
Earnings & Estimates Summary - XENOPORT INC (XNPT)
2013 revenues at Xenoport, Inc. totaled $8.0M USD, while annual losses equaled $1.81 per share.
Quarterly Earnings & Estimates - XENOPORT INC (XNPT)
Xenoport, Inc.'s Quarterly Earnings
Xenoport, Inc. reported 2nd quarter 2014 losses of $0.31 per share on 08/8/2014.
Annual Earnings & Estimates - XENOPORT INC (XNPT)
Xenoport, Inc.'s Annual Earnings
Xenoport, Inc. reported annual 2013 losses of $1.81 per share on 02/22/2014.
Quarterly Revenues - XENOPORT INC (XNPT)
Xenoport, Inc.'s Quarterly Revenues
Xenoport, Inc. had 2nd quarter 2014 revenues of $5.3M USD. This bettered the $4.8M USD consensus of the 4 analysts covering the company. This was 155.7% above the prior year's 2nd quarter results.
Annual Revenues - XENOPORT INC (XNPT)
Xenoport, Inc.'s Annual Revenues
Xenoport, Inc. had revenues for the full year 2013 of $8.0M USD. This was -63.2% below the prior year's results.
|Abeona Therapeutics Inc||$4.22 USD||+0.07|
|Alkermes PLC||$59.90 USD||-0.08|
|Skyepharma PLC||339.00 GBp||-0.75|
|Teva Pharmaceutical Industries Ltd||$59.24 USD||+0.69|
|Valeant Pharmaceuticals International Inc||C$222.89 CAD||+0.85|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|